Gene expression profiling in the mammary gland of rats treated with 7,12-dimethylbenz[a]anthracene

International Journal of Cancer

Volumn 118, Issue 1, 2006, Pages 17-24

  Papaconstantinou, Andriana D ^a   Shanmugam, Ilanchezhian ^a   Shan, Liang ^a   Schroeder, Insa S ^a   Qiu, Cunping ^a   Yu, Minshu ^a   Snyderwine, Elizabeth G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

7,12 dimethylbenz a anthracene (DMBA); Heat shock protein; Microarray analysis; Microtubule; Rat mammary gland

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ALPHA TUBULIN; BETA 2 MICROGLOBULIN; BETA CASEIN; CADHERIN; CALCYCLIN; CALSEQUESTRIN; CARCINOGEN; COMPLEMENTARY DNA; CREATINE KINASE; CRYSTALLIN; CYCLIN D1; ENOLASE; FURIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 86; KI 67 ANTIGEN; LIPOCORTIN 1; LIPOPOLYSACCHARIDE BINDING PROTEIN; MYOSIN; NUCLEAR FACTOR I; PARVALBUMIN; PROTEIN DISULFIDE ISOMERASE; PROTHYMOSIN ALPHA; RAN PROTEIN; STATHMIN; TRANSFERRIN; TROPOMYOSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; CYTOSKELETON; DNA MICROARRAY; DNA REPLICATION; EARLY CANCER; FEMALE; GENE EXPRESSION PROFILING; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIPOGENESIS; MAMMARY GLAND; METABOLISM; MICROTUBULE; MUSCLE CONTRACTION; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; RNA PROCESSING; STATISTICAL ANALYSIS; WESTERN BLOTTING;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOGENS; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; MAMMARY GLANDS, ANIMAL; MICROTUBULES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 27944439305     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21247     Document Type: Article

References (51)

1. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ. Biology of disease: comparative study of human and rat mammary tumorigenesis. Lab Invest 1990;62:244-78.
2. Russo IH, Russo J. Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst 1978;61:1439-49.
3. Frei JV, Harasono T. Increased susceptibility to low doses of a carcinogen of epidermal cells in stimulated DNA synthesis. Cancer Res 1967;27:1482.
4. Russo J, Russo IH. Biology of disease: biological and molecular bases of mammary carcinogehesis. Lab Invest 1987;57:112-37.
5. Shan L, Yu M, Schut HA, Snyderwine EG. Susceptibility of rats to mammary gland carcinogenesis by the food-derived carcinogen 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP) varies with age and is associated with the induction of differential gene expression. Am J Pathol 2004;165:191-202.
6. Gammal EB, Carroll KK, Plunkett ER. Effects of dietary fat on mammary carcinogenesis by 7,12-dimethylbenz[a]anthracene in rats. Cancer Res 1967;27:1737-42.
7. Qiu C, Shan L, Yu M, Snyderwine EG. Deregulation of the cyclin D1/Cdk4 retinoblastoma pathway in rat mammary gland carcinomas induced by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine. Cancer Res 2003;63:5674-8.
8. Bowyer JF, Davies DL. Changes in mRNA levels for heat-shock/stress proteins (Hsp) and a secretory vesicle associated cysteine-string protein (Csp1) after amphetamine (AMPH) exposure. Ann NY Acad Sci 1999;890:314-29.
9. Shan L, He M, Yu M, Qiu C, Lee NH, Liu ET, Snyderwine EG. cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6- phenylimidazo[4, 5-b]pyridine and 7,12-dimethylbenz[a]anthracene. Carcinogenesis 2002;23:1561-8.
10. Yano M, Naito Z, Tanaka S, Asano G. Expression and roles of heat shock proteins in human breast cancer. Jpn J Cancer Res 1996;87:908-15.
11. Horman S, Fokan D, Mosselmans R, Mairesse N, Galand P. Antisense inhibition of small-heat shock-protein (hsp27) expression in MCF-7 mammary carcinoma cells induces their spontaneous acquisition of a secretory phenotype. Int J Cancer 1999;82:574-82.
12. Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JCF, Lashkari D, Shalon D, et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A 1999;96:9212-7.
13. Thompson HJ, McGinely JN, Wolfe P, Singh M, Steele VE, Kelloff GJ. Temporal sequence of mammary intraductal proliferations, ductal carcinomas in situ and adenocarcinomas induced by 1-methyl-1-nitrosourea in rats. Carcinogenesis 1998;19:2181-5.
14. Yu M, Snyderwine EG. H-ras oncogene mutations during development of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP)-induced rat mammary gland cancer. Carcinogenesis 2002;23:2123-8.
15. Roberts-Thomson SJ, Snyderwine EG. mRNA differential display of 2-amino-1-mehtyl-6-phenylimidazo [4, 5-b]pyridine-induced rat mammary gland tumors. Breast Cancer Res Treat 1998;51:99-107.
16. Zhu Z, Jiang W, Thompson HJ. Effect of energy restriction on the expression of cyclin D1 and p27 during premalignant and malignant stages of chemically induced mammary carcinogenesis. Mol Carcinogen 1999;24:241-5.
17. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994;369:669-71.
18. Sgambato A, Han EK, Zhang YJ, Moon RC, Santell RM, Weinstein IB. Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors. Carcinogenesis 1995;16:2193-8.
19. Matsumura I, Kitamura T, Wakao H, Tanaka H, Hashimoto K, Albanese C, Downward J, Pestell RG, Kanakura Y. Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBOJ 1999;18:1367-77.
20. Yu H, Jove R. The stats of cancer: new molecular targets come of age. Nat Rev 2004;4:97-105.
21. Karim R, Tse G, Putti T, Scolyer R, Lee S. The significance of the Wnt pathway in the pathology of human cancers. Pathology 2004;36:120-8.
22. Kim DW, Sovak MA, Zanieski G, Nonet G, Romieu-Mourez R, Lau AW, Hafer LJ, Yaswen P, Stampfer M, Rogers AE, Russo J, Sonenshein GE. Activation of NF-kB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis 2000;21:871-9.
23. Morimoto RI, Kline MP, Bimston DN, Cotto JJ. The heat-shock response: regulation and function of heat-shock proteins and molecular chaperones. Essays Biochem 1997;32:17-29.
24. Beliakoff J, Whitesell L. Hsp90: an emerging target for breast cancer therapy. Anti-Cancer Drugs 2004;15:651-62.
25. Pratt WB, Welsh MJ. Chaperone functions of the heat shock proteins associated with steroid receptors. Semin Cell Biol 1994;5:83-93.
26. Yano M, Naito Z, Yokoyama M, Shiraki Y, Ishiwata T, Inokuchi M, Asano G. Expression of hsp9.0 and cyclin D1 in human breast cancer. Cancer Lett 1999;137:45-51.
27. Kuramoto T, Morimura K, Yamashita S, Okochi E, Watanabe N, Ohta T, Ohki M, Fukushima S, Sugimura T, Ushijima T. Etiology-specific gene expression profiles in rat mammary carcinomas. Cancer Res 2002;62:3592-7.
28. O'Neil PA, Shaaban AM, West CR, Dodson A, Jarvis C, Moore P, Davies MP, Sibson DR, Foster CS. Increased risk of malignant progression in benign proliferating breast lesions defined by expression of heat shock protein 27. Br J Cancer 2004;90:182-8.
29. Curmi PA, Andersen SSL, Lachkar S, Gavet O, Karsenti E, Knossow M, Sobel A. The stathmin tubulin interaction in vitro. J Biol Chem 1997;272:149-52.
30. Belmont LD, Mitchison TJ. Identification of a protein that interacts with tubulin dimmers and increases the catastrophe rate of microtubules. Cell 1996;84:623-31.
31. Alli E, Baqsh-Babula J, Yang JM, Hait WN. Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Cancer Res 2002;62:6864-9.
32. Jeha S, Luo X, Beran M, Kantarjian H, Atweh GF. Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemic cells. Cancer Res 1996;56:1445-50.
33. Koppel J, Loyer P, Maucuer A, Rehak P, Manceau V, Guguen-Guillouzo C, Sobel A. Induction of stathmin expression during liver regeneration. FEBS Lett 1993;331:65-70.
34. Bieche I, Lachkar S, Becette V, Cifuentes-Diaz C, Sobel A, Lidereau R, Curmi PA. Overexpression of the stathmin gene in a subset of human breast cancer. Br J Cancer 1998;78:701-9.
35. Brattsand G. Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors. Br J Cancer 2000;83:311-8.
36. Curmi PA, Noguès C, Lachkar S, Carelle N, Gonthier MP, Sobel A, Lidereau R, Bieche I. Overexpression of stathmin in breast carcinomas points out to highly proliferative tumors. Br J Cancer 2000;82:142-50.
37. Wulfkuhle JD, Sgroi DC. Krutzsch H, McLean K, McGarvey K, Knowlton M, Chen S, Shu H, Sahin A, Kurek R, Wallwiener D, Merino MJ, et al. Proteomics of human breast ductal carcinoma in situ. Cancer Res 2002;62:6740-9.
38. Sazer S, Dasso M. The ran decathlon: multiple roles of Ran. J Cell Sci 2000;113:1111-8.
39. Carazo-Salas RE, Gruss OJ, Mattaj IW, Karsenti E. Ran-GTP coordinates regulation of microtubule nucleation and dynamics during mitotic-spindle assembly. Nat Cell Biol 2001;3:228-34.
40. Wilde A, Lizarraga SB, Zhang L, Wiese C, Gliksman NR, Walczak CE, Zheng Y. Ran stimulates spindle assembly by altering microtubule dynamics and the balance of motor activities. Nat Cell Biol 2001;3:221-7.
41. Eyers PA, Mailer JL. Regulating the regulators: aurora A activation and mitosis. Cell Cycle 2003;2:287-9.
42. Trieselmann N, Armstrong S, Rauw J, Wilde A. Ran modulates spindle assembly by regulating a subset of TPX2 and Kid activities including aurora A activation. J Cell Sci 2003;116:4791-8.
43. Goepfert TM, Adigun YE, Zhong L, Gay J, Medina D, Brinkley WR. Centrosome amplification and overexpression of aurora A are early events in rat mammary carcinogenesis. Cancer Res 2002;62:4115-22.
44. Lange BM, Bachi A, Wilm M, Gonzalez C. Hsp90 is a core centrosomal component and is required at different stages of the centrosome cycle in Drosophila and vertebrates. EMBO J 2000;19:1252-62.
45. Hino M, Kurogi K, Okubo MA, Murata-Hori M, Hosoya H. Small heat shock protein 27 (hsp27) associates with tubulin/microtubules in HeLa cells. Biochem Biophys Res Commun 2000;271:164-9.
46. Fuqua SA, Oesterreich S, Hilsenbeck SG, Von Hoff DD, Eckardt J, Osborne CK. Heat shock proteins and drug resistance. Breast Cancer Res Treat 1994;32:67-71.
47. Oesterreich S, Weng CN, Qiu M, Hilsenbeck SG, Osborne CK, Fuqua SA. The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res 1993;53:4443-8.
48. Iancu C, Mistry SJ, Arkin S, Atweh GF. Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemic cells. Cancer Res 2000;60:3537-41.
49. Mistry SJ, Atweh GF. Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy. Mount Sinai J Med 2002;69:299-304.
50. Cragg GM, Newman DJ. A tale of two tumor targets: topoisomerase I and tubulin-the Wall and Wani contribution to cancer chemotherapy. J Nat Prod 2004;67:232-44.
51. Orr GA, Verdier-Pinard P, McDaid H, Horwitz SB. Mechanisms of Taxol resistance related to microtubules. Oncogene 2003;22:7280-95.